Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- ChecktodayChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe study page now shows a 403 Forbidden error, blocking access to the study record. The header and footer remain visible, but the actual study details cannot be retrieved.SummaryDifference18%

- Check49 days agoChange DetectedA note about a 2017 NIH grant/contract was added, and the site revision was updated to v3.6.6, replacing v3.6.5.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision tag changed from v3.6.4 to v3.6.5, representing a new revision in the page's version history rather than a change to study content.SummaryDifference0.0%

- Check85 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a routine platform/content-management update.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.